Gal-3 plays a major role in the pathophysiology of HF, as a marker and a mechanism of inflammation potentially leading to fibrosis [36], but little is known about the implication of Gal-3 in the CV complications among patients on dialysis. Here, LGALS3 is linked to hydrops fetalis.